Germany’s ITM receives material license to produce Lu-177

January 9, 2024, 12:01PMNuclear News
Bavarian minister of state Florian Herrmann (left) with ITM CEO Steffen Schuster (right) and others at a mock-up Lu-177 hot cell. (Photo: ITM)

Radiopharmaceutical biotech company ITM Isotope Technologies Munich announced it has received regulatory approval to begin production of the medical radioisotope lutetium-177 at the company’s NOVA facility in Neufahrn, near Munich, Germany.

To continue reading, log in or create a free account!

Related Articles

Remembering the Savannah River Plant

December 17, 2024, 2:59PMNuclear NewsJay Bilyeu

In 1989, the Savannah River Plant was renamed the Savannah River Site. It was originally established in 1950 near Aiken, S.C., to produce nuclear materials for the nation, primarily for...